Back

Bausch Health Companies Inc.

Case Details

Class Period: August 6, 2020 - May 3, 2023
Date Filed: July 26, 2023
Case Number: 3:23cv03996
Jurisdiction: District of New Jersey
icon-casetype Case Type: Securities Case
Days Left to
Seek Plaintiff:
2

Case Summary

The complaint alleges that defendants made false and/or misleading statements about the Company’s spinoff of the Bausch + Lomb Corporation (“B+L”), including the benefits it would provide for Bausch shareholders and the effects it would have on Bausch post-spinoff. The complaint also alleges that the spinoff was done not to benefit shareholders but instead to undermine plaintiff lawsuits stemming from securities laws violations in 2016.

Defendants’ statements about the B+L spinoff have caused significant damages for Bausch investors. On August 6, 2020, when the spinoff was announced, Bausch’s stock closed at $20.13 per share. The stock traded as high as $34.38 per share before falling to its current trading prices of under $10 per share.

Documents
Complaint